TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2276015

Group type: EXPERIMENTAL
Intervention: Rehydrated Hemoccult II test with retesting
Number of subjects: 3561

Group type: COMPARATOR
Intervention: Rehydrated Hemoccult II test without retesting
Number of subjects: 3561

Group type: EXPERIMENTAL
Intervention: Rehydrated Hemoccult II test with retesting in second screening
Number of subjects: 3561

Group type: COMPARATOR
Intervention: Rehydrated Hemoccult II test with negative retest in second screening
Number of subjects: 3561
Study: 365332

Group type: EXPERIMENTAL
Intervention: Physical training for 2 months
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Lidoflazine 240 mg/day for 5 months
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 29023327

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) supplementation (0.2 g·kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (sodium chloride, NaCl)
Number of subjects: 10
Study: 29723074

Group type: EXPERIMENTAL
Intervention: Arousal condition (23 participants)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Suppression condition (21 participants)
Number of subjects: 44
Study: 28974835

Group type: EXPERIMENTAL
Intervention: Surgical therapy with bone replacement material (group 2)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Surgical therapy without bone replacement material (group 1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (group 1 and group 2)
Number of subjects: 50
Study: 26160221

Group type: EXPERIMENTAL
Intervention: Treadmill desk (used for at least one hour per day for 13 months)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Health consultation + Treadmill desk
Number of subjects: 80

Group type: COMPARATOR
Intervention: Health consultation + Regular workstation
Number of subjects: 80
Study: 23384207

Group type: EXPERIMENTAL
Intervention: In-line filtration
Number of subjects: 807

Group type: COMPARATOR
Intervention: Control group (no filtration)
Number of subjects: 807
Study: 21676001

Group type: EXPERIMENTAL
Intervention: Delay discounting task during functional magnetic resonance imaging (fMRI)
Number of subjects: 151
Study: 18037022

Group type: EXPERIMENTAL
Intervention: Betablocker (propranolol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15618337

Group type: EXPERIMENTAL
Intervention: Carbohydrate loading
Number of subjects: 8

Group type: COMPARATOR
Intervention: Non-loaded diet
Number of subjects: 8
Study: 12183305

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 369

Group type: COMPARATOR
Intervention: Non-epidural analgesia
Number of subjects: 369
Study: 10102310

Group type: EXPERIMENTAL
Intervention: Rigid Philadelphia collar
Number of subjects: 20
Study: 7594703

Group type: EXPERIMENTAL
Intervention: HIV‐1-infected cells in breast milk
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Severe vitamin A deficiency
Number of subjects: 107
Study: 1968871

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (600 mg/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Taurine (1.5 g/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid plus taurine (600 mg + 1.5 g/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 367885

Group type: EXPERIMENTAL
Intervention: 1 g/day cimetidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 g/day cimetidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cimetidine (1 g and 2 g)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0
Study: 31692851

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg once daily for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28733799

Group type: EXPERIMENTAL
Intervention: Incredible Years Parents, Babies and Toddlers program with depression psychoeducation (12 weekly sessions)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 61
Study: 25998921

Group type: EXPERIMENTAL
Intervention: Intervention group (Strategies To Enhance Practice)
Number of subjects: 1700

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1700
Study: 23508626

Group type: COMPARATOR
Intervention: Placebo arm of a randomized treatment sequence
Number of subjects: 6
Study: 20346195

Group type: EXPERIMENTAL
Intervention: Preferred treatment
Number of subjects: 220

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 220
Study: 19769721

Group type: EXPERIMENTAL
Intervention: recombinant human GM-CSF hydrogel
Number of subjects: 90

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 90
Study: 17901013

Group type: EXPERIMENTAL
Intervention: Occupational therapy with videotape feedback
Number of subjects: 10

Group type: COMPARATOR
Intervention: Occupational therapy only
Number of subjects: 10
Study: 15605645

Group type: EXPERIMENTAL
Intervention: Citriodiol spray applied daily for 2 weeks to the lower extremities
Number of subjects: 111

Group type: COMPARATOR
Intervention: No repellent used
Number of subjects: 111
Study: 11552915

Group type: EXPERIMENTAL
Intervention: Colchicine and Ursodeoxycholic acid (U + C)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ursodeoxycholic acid and placebo (U + P)
Number of subjects: 44
Study: 9973779

Group type: EXPERIMENTAL
Intervention: Aggressive imagery technique
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Relaxation imagery technique
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control condition (discussions)
Number of subjects: 48
Study: 8045061

Group type: EXPERIMENTAL
Intervention: Compression ultrasound (US)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Venous blood pool scintigraphy (BPS)
Number of subjects: 76
Study: 3377933

Group type: EXPERIMENTAL
Intervention: sublingual nifedipine 10 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo capsules
Number of subjects: 40
Study: 31834056

Group type: EXPERIMENTAL
Intervention: Orphenadrine
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 30300378

Group type: EXPERIMENTAL
Intervention: Intermanual transfer training program with mirror therapy and motor imagery
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Intermanual transfer training program only
Number of subjects: 47

Group type: COMPARATOR
Intervention: Sham training (dummy training without using the prosthesis simulator)
Number of subjects: 47
Study: 26610333

Group type: EXPERIMENTAL
Intervention: 600 mcg of misoprostol administered after birth when oxytocin was not available
Number of subjects: 2466

Group type: COMPARATOR
Intervention: Standard-of-care (control arm)
Number of subjects: 2466
Study: 24055414

Group type: EXPERIMENTAL
Intervention: Vorinostat (400 mg orally once daily on days 1-14) in combination with bortezomib (1.3 mg/m² intravenously on days 1, 4, 8, and 11)
Number of subjects: 637

Group type: COMPARATOR
Intervention: Placebo (matching placebo orally once daily on days 1-14) in combination with bortezomib (1.3 mg/m² intravenously on days 1, 4, 8, and 11)
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Vorinostat
Number of subjects: 637

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 637
Study: 21438016

Group type: EXPERIMENTAL
Intervention: Brief cognitive-behavioral intervention
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 17712060

Group type: EXPERIMENTAL
Intervention: Turkey cutlets soaked in red wine after heating plus 200 ml of red wine (B)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Turkey cutlets soaked in red wine prior to heating plus 200 ml of red wine (C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Turkey cutlets supplemented by water (A)
Number of subjects: 10
Study: 15343157

Group type: EXPERIMENTAL
Intervention: Ethylenediamine tetraacetic acid (Group EA)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: H3PO4 (Group PA3)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: H3PO4 + NaOCl (Group PA120)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: HCl + NaOCl (Group CA)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (Group N)
Number of subjects: 8
Study: 14510110

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 12
Study: 9481269

Group type: EXPERIMENTAL
Intervention: Venous aPTT values
Number of subjects: 0

Group type: COMPARATOR
Intervention: aPTT values from heparinized arterial lines
Number of subjects: 0
Study: 7518480

Group type: EXPERIMENTAL
Intervention: Simultaneous infusion of substance P (11.2 pmol/min) plus adenosine (125 to 2000 micrograms/min) during intrailiac infusion
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Simultaneous infusion of substance P (11.2 pmol/min) plus adenosine (50 to 800 micrograms/min) during intracoronary infusion
Number of subjects: 17

Group type: COMPARATOR
Intervention: Adenosine infusion (125 to 2000 micrograms/min) during intrailiac infusion
Number of subjects: 17

Group type: COMPARATOR
Intervention: Adenosine infusion (50 to 800 micrograms/min) during intracoronary infusion
Number of subjects: 17
Study: 3290870

Group type: EXPERIMENTAL
Intervention: High-dose regimen (1,650 mg/day)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Low-dose regimen (day 1, 1,100 mg; day 2, 825 mg)
Number of subjects: 99
Study: 30041526

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (8×10^9 CFU/day for 12 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (one capsule daily for 12 weeks)
Number of subjects: 50
Study: 27175706

Group type: EXPERIMENTAL
Intervention: SVV-guided fluid therapy (SVV maintained at 10%-20%)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (SVV maintained at <10%)
Number of subjects: 48
Study: 25069393

Group type: EXPERIMENTAL
Intervention: Intervention consisting of plenary meetings and individual visits at construction worksites
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intervention consisting of questionnaires for behavioral and organizational determinants
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Process evaluation of the intervention
Number of subjects: 8
Study: 23158273

Group type: EXPERIMENTAL
Intervention: Ilaprazole-based bismuth-containing quadruple regimen
Number of subjects: 440

Group type: COMPARATOR
Intervention: Esoprazole-based bismuth-containing quadruple regimen
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Total eradication rate
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Symptomatic improvements
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Clarithromycin resistance
Number of subjects: 440
Study: 20881072

Group type: EXPERIMENTAL
Intervention: Phylloquinone (1 mg daily for 12 months)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 18603233

Group type: EXPERIMENTAL
Intervention: Visual-Auditory presentation (AV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual only (VO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Auditory only (AO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Audio-Visual (AV) condition
Number of subjects: 0
Study: 16207220

Group type: EXPERIMENTAL
Intervention: FCS educational packages (six different packages, each containing three FCS educational sheets)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: FCS educational packages
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: FCS educational materials
Number of subjects: 36
Study: 11383320

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 26

Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 26
Study: 9758075

Group type: EXPERIMENTAL
Intervention: Relevant acupuncture
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Irrelevant acupuncture
Number of subjects: 46

Group type: COMPARATOR
Intervention: No-acupuncture control (nonsteroidal anti-inflammatory medication)
Number of subjects: 46
Study: 7838418

Group type: EXPERIMENTAL
Intervention: Topical estrogen plus cetyltrimethylammonium naproxenate douches
Number of subjects: 34

Group type: COMPARATOR
Intervention: Estrogen topical therapy
Number of subjects: 34
Study: 3045545

Group type: EXPERIMENTAL
Intervention: Corticosteroids for 10 weeks plus daily azathioprine for one year
Number of subjects: 46

Group type: COMPARATOR
Intervention: No immunosuppressive therapy (Control)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Corticosteroids plus azathioprine
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 46
Study: 31796677

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-aerobic stretching and toning (SAT)
Number of subjects: 70
Study: 30844471

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personalized diet using a machine-learning algorithm
Number of subjects: 0
Study: 28506940

Group type: EXPERIMENTAL
Intervention: Hypothermia group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 25732250

Group type: EXPERIMENTAL
Intervention: 0.4mg fludrocortisone
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 23656203

Group type: EXPERIMENTAL
Intervention: Oral, modified-release tranexamic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21907863

Group type: EXPERIMENTAL
Intervention: Airway bypass (n=208)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Sham control (n=107)
Number of subjects: 315
Study: 19541304

Group type: EXPERIMENTAL
Intervention: Controlled cord traction (CCT)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Hands-off management
Number of subjects: 204
Study: 17116916

Group type: EXPERIMENTAL
Intervention: Disease management program led by care managers for 238 patient-caregiver pairs at 9 intervention clinics for more than 12 months.
Number of subjects: 408

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 408
Study: 15648470

Group type: EXPERIMENTAL
Intervention: Pleasant group (viewed pleasant photographs)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Unpleasant group (viewed unpleasant photographs)
Number of subjects: 32
Study: 11352412

Group type: EXPERIMENTAL
Intervention: Shared decision making
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Role mismatch
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Perceived role in decision making
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Exclusive decision making by doctor or patient
Number of subjects: 233
Study: 9499664

Group type: EXPERIMENTAL
Intervention: Idarubicin (IDA) and cytosine arabinoside (Ara‐C) induction therapy for patients < 65 years: Ara‐C 1 g/m2/day i.v. 6‐hour infusion on days 1‐4, IDA 10 mg/m2/day i.v. on days 1‐3.
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Idarubicin (IDA) and cytosine arabinoside (Ara‐C) induction therapy for elderly patients (>= 65 years): Ara‐C 1 g/m2/day 6 hours infusion on days 1 and 2, IDA 10 mg/m2/day i.v. on days 1 and 2.
Number of subjects: 25
Study: 8190575

Group type: EXPERIMENTAL
Intervention: Nebulized albuterol
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Oral albuterol
Number of subjects: 88

Group type: COMPARATOR
Intervention: Nebulized saline
Number of subjects: 88

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 88
Study: 31509210

Group type: EXPERIMENTAL
Intervention: Text-messaging program (MyTeen) for parents, 1 daily text message over 4 weeks
Number of subjects: 221
Study: 29909907

Group type: EXPERIMENTAL
Intervention: Cixutumumab (CIX) 10 mg/kg alone
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Cixutumumab (CIX) 10 mg/kg with Cetuximab (CET) 500 mg/m2 every 2 weeks
Number of subjects: 91

Group type: COMPARATOR
Intervention: CET alone (historical data)
Number of subjects: 91
Study: 27090868

Group type: EXPERIMENTAL
Intervention: CVT-301 (levodopa inhalation powder)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 25222385

Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT) plus home exercise and advice (HEA) for 12 weeks
Number of subjects: 192

Group type: COMPARATOR
Intervention: Home exercise and advice (HEA) alone for 12 weeks
Number of subjects: 192
Study: 22951407

Group type: EXPERIMENTAL
Intervention: Web-based multidisciplinary intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study: 20930337

Group type: EXPERIMENTAL
Intervention: Chronic periodontitis patients with atherosclerosis (Group A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Chronic periodontitis patients without systemic disease (Group B)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Clinically healthy individuals (Group C)
Number of subjects: 45
Study: 18446415

Group type: EXPERIMENTAL
Intervention: Pocket reference including information about pain and symptom control and 1-2 didactic end-of-life teaching sessions per month.
Number of subjects: 136

Group type: COMPARATOR
Intervention: Didactic sessions only (control group).
Number of subjects: 136
Study: 17179480

Group type: EXPERIMENTAL
Intervention: 10 fractions of 3 Gy (10 x 3 Gy)
Number of subjects: 297

Group type: COMPARATOR
Intervention: 2 fractions of 8 Gy (2 x 8 Gy)
Number of subjects: 297
Study: 14657819

Group type: EXPERIMENTAL
Intervention: Heparin (0.5 IU/mL)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 296
Study: 10639376

Group type: EXPERIMENTAL
Intervention: Cyclodextrin solution of itraconazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Itraconazole capsules
Number of subjects: 0
Study: 8799519

Group type: EXPERIMENTAL
Intervention: Intravenous fluticasone propionate (FP)
Number of subjects: 0
Study: 1463945

Group type: EXPERIMENTAL
Intervention: Graduated compression
Number of subjects: 200
Study: 6469177

Group type: EXPERIMENTAL
Intervention: Diet T (high butter content)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Diet P (high margarine content)
Number of subjects: 30
Study: 31540616

Group type: EXPERIMENTAL
Intervention: Employed at end-of-treatment
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Unemployed at baseline and acquired employment by end-of-treatment
Number of subjects: 553

Group type: COMPARATOR
Intervention: Unemployed at baseline and remained unemployed by end-of-treatment
Number of subjects: 553
Study: 29113548

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg + Solifenacin 10 mg per day (Group A, N = 93)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg + Solifenacin 20 mg (Group B, N = 83)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg + Placebo (Control Group C, N = 86)
Number of subjects: 262
Study: 26898348

Group type: EXPERIMENTAL
Intervention: SFC DPI (50/250 μg twice daily)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: SFC pMDI (four puffs of 25/125 μg daily)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Patients >70 years old (n = 21)
Number of subjects: 47
Study: 25356992

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (8-week curriculum)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 50
Study: 23158275

Group type: EXPERIMENTAL
Intervention: Permanent pacemaker implantation (PPI)
Number of subjects: 108
Study: 20873891

Group type: EXPERIMENTAL
Intervention: Multidimensional Family Therapy (MDFT)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: MDFT-detention to community
Number of subjects: 378
Study: 17148567

Group type: COMPARATOR
Intervention: Soy protein isolate with 0 mg isoflavones
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Soy protein isolate with 97.5 mg isoflavones
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Soy protein isolate with 135.5 mg isoflavones
Number of subjects: 13
Study: 14976604

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) plus didanosine or zalcitabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) monotherapy
Number of subjects: 0
Study: 12370800

Group type: EXPERIMENTAL
Intervention: 10 mg alendronate and 500 mg calcium daily (n = 8)
Number of subjects: 19

Group type: COMPARATOR
Intervention: 500 mg calcium daily (n = 11)
Number of subjects: 19
Study: 9830242

Group type: EXPERIMENTAL
Intervention: Alcoholic beverages
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonalcoholic beverages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol with pleasant photographic slides
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonalcoholic with pleasant photographic slides
Number of subjects: 0
Study: 8628584

Group type: EXPERIMENTAL
Intervention: Relaxation and imagery training
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral coping skills package (including relaxation and imagery)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Therapist support
Number of subjects: 94

Group type: COMPARATOR
Intervention: Treatment as usual control
Number of subjects: 94
Study: 2655606

Group type: EXPERIMENTAL
Intervention: Chlorambucil (0.05‐0.1 mg/kg/day)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 773494

Group type: EXPERIMENTAL
Intervention: Atenolol (three different doses taken once daily for four weeks)
Number of subjects: 0
Study: 31324487

Group type: EXPERIMENTAL
Intervention: School-based hand hygiene program
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 6
Study: 27471824

Group type: EXPERIMENTAL
Intervention: 25-gauge trocar cannula technique
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard vitreous tap and injection technique
Number of subjects: 18
Study: 26079405

Group type: COMPARATOR
Intervention: Statin therapy (pravastatin) initiated in childhood, duration 10 years
Number of subjects: 214
Study: 23523573

Group type: EXPERIMENTAL
Intervention: Thenar eminence (TE) grip
Number of subjects: 60

Group type: COMPARATOR
Intervention: E-C clamp (EC) grip
Number of subjects: 60

Group type: COMPARATOR
Intervention: E-C clamp (EC) grip first, then Thenar eminence (TE) grip
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thenar eminence (TE) grip first, then E-C clamp (EC) grip
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Thenar eminence (TE) grip (first 12 breaths)
Number of subjects: 60

Group type: COMPARATOR
Intervention: E-C clamp (EC) grip (first 12 breaths)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both grips
Number of subjects: 60